|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.98 USD | +2.29% |
|
+0.95% | -31.13% |
| 05-07 | Needham Cuts Price Target on Azenta to $33 From $44, Keeps Buy Rating | MT |
| 05-06 | Azenta, Inc., Q2 2026 Earnings Call, May 06, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AZENTA, INC. | Other Biotechnology & Medical Research | +1.96% | +0.95% | -31.13% | -24.68% | -77.31% | 1.04B |  |  | |
- Stock Market
- Stocks
- AZTA Stock
- Charts Azenta, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
